Close
Smartlab Europe
Achema middle east

Press Releases

AmerisourceBergen Reaches agreement with US CDC to support independent retail pharmacies access to COVID-19 vaccine

AmerisourceBergen has reached an agreement with the U.S. Centers for Disease Control and Prevention (CDC) to include Good Neighbor Pharmacy and Elevate Provider Network members in the Federal Pharmacy Partnership Strategy for COVID-19 Vaccination. To support access, AmerisourceBergen will serve...

The world’s leading conference dedicated solely to extractables and leachables returning in a new online format

The event, renowned in the industry for providing all of the latest E&L updates, case studies and more, will take place from 1-2 December as an online event. You can expect the same unmissable content, high-calibre speakers and unique...

Novavax Announces Facility Expansion to Support Global Vaccine Development

Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced the expansion of its Maryland campus to accommodate the company’s rapid growth as it works to develop its candidate vaccine against COVID-19 and advance its...

AirBridgeCargo Airlines expands its partnership with Sonoco ThermoSafe to embrace new Pegasus ULD passive container

AirBridgeCargo Airlines, part of Volga-Dnepr Group, expands its Master Lease Agreement with Sonoco ThermoSafe to enable its customers worldwide to transport life-saving and healthcare products within Pegasus ULD passive container (passive container – ULD capable to maintain internal temperature...

Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution

Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from clinical through commercialization,  announced a strategic collaboration with Synexa Life Sciences, a world-leading expert in biomarker and bioanalytical science,...

Lonza Announces Agreement to Manufacture AstraZeneca’s COVID-19 Long-Acting Antibody Combination

Lonza announced that the company has signed an agreement with AstraZeneca to manufacture AZD7442, a combination of two long-acting antibodies (LAABs) for the potential prevention and treatment of COVID-19. AZD7442 is currently in Phase I clinical studies and AstraZeneca...

Kintor Pharmaceutical’s COVID-19 Clinical Trials for Proxalutamide to expand Patient Enrolment

Kintor Pharmaceutical Limited is delighted to announced that the clinical trial of anti-androgen treatment Proxalutamide (GT0918) for the novel coronavirus disease (COVID-19) has reached the initial target of 381 patients enrolment on 25 October 2020. Also, it has demonstrated...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »